Sales Nexus CRM

HeartBeam and Mount Sinai Collaborate to Develop AI-Driven ECG Algorithms for Remote Cardiac Monitoring

By FisherVista
HeartBeam (NASDAQ: BEAT) is collaborating with Mount Sinai to develop and validate AI-based ECG algorithms for its cable-free 12-lead ECG platform, aiming to enhance remote cardiac monitoring and data-driven healthcare.

Found this article helpful?

Share it with your network and spread the knowledge!

HeartBeam and Mount Sinai Collaborate to Develop AI-Driven ECG Algorithms for Remote Cardiac Monitoring

HeartBeam (NASDAQ: BEAT) is collaborating with Mount Sinai to advance artificial intelligence-driven electrocardiogram technology, according to a recent article highlighting the partnership. The collaboration focuses on developing and validating high-value AI-based ECG algorithms that can be deployed across HeartBeam's platform, potentially including patient-relevant wellness insights, condition-focused assessments, and applications for chronic condition management. This move underscores HeartBeam's growing emphasis on AI-enabled analysis and reinforces the relevance of its technology as healthcare shifts toward data-driven, remote monitoring solutions.

HeartBeam is a medical technology company dedicated to transforming cardiac care by providing cardiac insights wherever the patient is. The company is creating the first-ever cable-free 12-lead ECG capable of capturing the heart's electrical signals from three dimensions. This platform technology is designed for portable devices that can be used anywhere to deliver actionable heart intelligence. Physicians will be able to identify cardiac health trends and acute conditions and direct patients to appropriate care outside of a medical facility, redefining the future of cardiac health management. The company holds 13 U.S. and four international issued patents related to its technology.

The partnership with Mount Sinai is significant because it aims to bring advanced AI algorithms to HeartBeam's platform, potentially improving the accuracy and utility of remote ECG monitoring. As healthcare increasingly adopts data-driven and remote monitoring solutions, this collaboration could help address the growing demand for tools that enable early detection and management of cardiac conditions. For patients, this could mean more convenient access to cardiac monitoring without the need for hospital visits, potentially leading to earlier intervention and better outcomes. For the industry, it represents a step toward integrating AI with portable ECG technology, which could reduce healthcare costs and improve efficiency.

The full article is available at https://ibn.fm/oTJHB. For more information about HeartBeam, visit www.HeartBeam.com. The latest news and updates relating to BEAT are available in the company's newsroom at https://ibn.fm/BEAT.

FisherVista

FisherVista

@fishervista